---
figid: PMC6088794__nihms-1500829-f0001
figlink: /pmc/articles/PMC6088794/figure/F1/
number: Figure 1
caption: 'Figure 1 highlights the androgen receptor (AR)-signaling axis, with conversion
  of testosterone to dihydrotestosterone (DHT) by the 5α-reductase enzyme, and subsequent
  AR activation, dimerization, nuclear translocation and activation of transcriptional
  activation of target genes. The figure summarizes potential mechanisms of resistance
  to AR-signaling inhibitors by using a schematic representation of a prostate cancer
  cell. Not shown are multiple additional androgen/AR-independent mechanisms of escape
  including activated Wnt pathway signaling, loss of the RB1 and/or TP53 genes, overexpression
  of DNA repair pathways proteins including PARP1 and DNA-PK, epigenetic dysregulation
  (e.g. via EZH2 overexpression), and neuroendocrine/small cell transformation.Abbreviations:
  CYP17: cytochrome P450 17alpha-hydroxylase; PI3K: phosphoinositide 3-kinase; AKT:
  protein kinase B; PTEN: phosphatase and tensin homolog; mTOR: mammalian target of
  rapamycin; NF-kB: nuclear factor kappa B; MDM2: mouse double minute 2 homolog; AR-V:
  AR splice variant; P: progesterone; PR: progesterone receptor; G: glucocorticoid;
  GR: glucocorticoid receptor.'
pmcid: PMC6088794
papertitle: CTC-derived AR-V7 detection as a prognostic and predictive biomarker in
  advanced prostate cancer.
reftext: Diogo A. Bastos, et al. Expert Rev Mol Diagn. 2018 Feb;18(2):155-163.
pmc_ranked_result_index: '41848'
pathway_score: 0.900835
filename: nihms-1500829-f0001.jpg
figtitle: Androgen receptor signaling axis and potential androgen-dependent and independent
  mechanisms of disease progression
year: '2018'
organisms: Homo sapiens
ndex: 6130ebf0-df13-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6088794__nihms-1500829-f0001.html
  '@type': Dataset
  description: 'Figure 1 highlights the androgen receptor (AR)-signaling axis, with
    conversion of testosterone to dihydrotestosterone (DHT) by the 5α-reductase enzyme,
    and subsequent AR activation, dimerization, nuclear translocation and activation
    of transcriptional activation of target genes. The figure summarizes potential
    mechanisms of resistance to AR-signaling inhibitors by using a schematic representation
    of a prostate cancer cell. Not shown are multiple additional androgen/AR-independent
    mechanisms of escape including activated Wnt pathway signaling, loss of the RB1
    and/or TP53 genes, overexpression of DNA repair pathways proteins including PARP1
    and DNA-PK, epigenetic dysregulation (e.g. via EZH2 overexpression), and neuroendocrine/small
    cell transformation.Abbreviations: CYP17: cytochrome P450 17alpha-hydroxylase;
    PI3K: phosphoinositide 3-kinase; AKT: protein kinase B; PTEN: phosphatase and
    tensin homolog; mTOR: mammalian target of rapamycin; NF-kB: nuclear factor kappa
    B; MDM2: mouse double minute 2 homolog; AR-V: AR splice variant; P: progesterone;
    PR: progesterone receptor; G: glucocorticoid; GR: glucocorticoid receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R6
  - PIK3R5
  - AKT1
  - AKT2
  - AR
  - CYP17A1
  - MDM2
  - MTOR
  - NFKB1
  - PIK3R4
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PTEN
  - PIK3CB
  - PIK3CD
  - AKT3
  - Testosterone
  - androgen
  - Androgen
  - HSD
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: CYP17&
  symbol: CYP17
  source: hgnc_prev_symbol
  hgnc_symbol: CYP17A1
  entrez: '1586'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
chemicals:
- word: Testosterone
  source: MESH
  identifier: D013739
- word: androgen
  source: MESH
  identifier: D000728
- word: Androgen
  source: MESH
  identifier: D000728
diseases:
- word: HSD
  source: OMIM
  identifier: '143095'
---
